UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.343-357

2019

Volltextzugriff (PDF)

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

Journal of clinical oncology, 2014-03, Vol.32 (8), p.768-773

2014

Volltextzugriff (PDF)

Potential biomarkers for lung cancer screening

Translational lung cancer research, 2014-06, Vol.3 (3), p.139-148

2014

Volltextzugriff (PDF)

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer

Cancers, 2019-06, Vol.11 (6), p.888

2019

Volltextzugriff (PDF)

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis

The cancer journal (Sudbury, Mass.), 2012-05, Vol.18 (3), p.268-274

2012

Volltextzugriff (PDF)

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Tumori, 2021-10, Vol.107 (5), p.446-451

2021

Volltextzugriff (PDF)

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer

European journal of cancer (1990), 2017-07, Vol.79, p.90-97

2017

Volltextzugriff (PDF)

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study

Clinical cancer research, 2019-04, Vol.25 (7), p.2166-2173

2019

Volltextzugriff (PDF)

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy

Annals of surgical oncology, 2019-03, Vol.26 (3), p.869-875

2019

Volltextzugriff (PDF)

Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial

Journal of thoracic oncology, 2022-11, Vol.17 (11), p.1276-1286

2022

Volltextzugriff (PDF)

Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

International journal of cancer, 2019-06, Vol.144 (11), p.2746-2761

2019

Volltextzugriff (PDF)

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening

Cancer epidemiology, biomarkers & prevention, 2022-11, Vol.31 (11), p.2020-2029

2022

Volltextzugriff (PDF)

Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy

Cancer gene therapy, 2024-06, Vol.31 (6), p.842-850

2024

Volltextzugriff (PDF)

A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer

Frontiers in oncology, 2022-07, Vol.12, p.911613-911613

2022

Volltextzugriff (PDF)

miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLC

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.e68-e70

2021

Volltextzugriff (PDF)

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene

Lung cancer (Amsterdam, Netherlands), 2012-09, Vol.77 (3), p.507-514

2012

Volltextzugriff (PDF)

Reply to comments on: Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Tumori, 2021-10, Vol.107 (5), p.472-473

2021

Volltextzugriff (PDF)

Effectiveness of Resective Surgery in Complex Ameloblastoma of the Jaws: A Retrospective Multicenter Observational Study

Cancers, 2022-09, Vol.14 (19), p.4608

2022

Volltextzugriff (PDF)

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Oncotarget, 2015-10, Vol.6 (32), p.32868-32877

2015

Volltextzugriff (PDF)

LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments

Journal of thoracic oncology, 2021-08, Vol.16 (8), p.1298-1311

2021

Volltextzugriff (PDF)

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes

Oncotarget, 2014-05, Vol.5 (9), p.2608-2621

2014

Volltextzugriff (PDF)

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers

Journal of thoracic oncology, 2017-06, Vol.12 (6), p.922-931

2017

Volltextzugriff (PDF)

Prognostic determinants in epithelioid sarcoma

European journal of cancer (1990), 2011-01, Vol.47 (2), p.287-295

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

Potential biomarkers for lung cancer screening

Exo-miRNAs as a New Tool for Liquid Biopsy in Lung Cancer

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy

Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial

Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening

Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy

A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer

miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLC

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene

Reply to comments on: Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Effectiveness of Resective Surgery in Complex Ameloblastoma of the Jaws: A Retrospective Multicenter Observational Study

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening–Detected Lung Cancers

Prognostic determinants in epithelioid sarcoma

Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy

Aktive Filter

Suchergebnisse filtern